Microbot Medical Inc (MBOT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
On January 29, 2024, the Company applied for an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration to begin a pivotal clinical trial in humans.
For further insights into MBOT stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.